Neogenomics (NEO) Cash from Operations Growth (1y) (2011 - 2026)
Neogenomics (NEO) Cash from Operations Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 30,529.42 Bn | 30,528.96 Bn | 1.11 Bn | -101.15% |
| 2 | Thermo Fisher Scientific | 183.75 Bn | 180.50 Bn | 7.74 Bn | 64.87% |
| 3 | Danaher | 133.13 Bn | 127.43 Bn | 3.59 Bn | 1.77% |
| 4 | Idexx Laboratories | 46.14 Bn | 45.94 Bn | 722.74 Mn | 11.89% |
| 5 | Agilent Technologies | 38.20 Bn | 36.39 Bn | 990.00 Mn | 25.34% |
| 6 | Natera | 31.50 Bn | 30.40 Bn | 696.04 Mn | -9.63% |
| 7 | Iqvia Holdings | 31.34 Bn | 29.36 Bn | 1.36 Bn | 8.80% |
| 8 | Illumina | 24.51 Bn | 23.36 Bn | 721.00 Mn | 20.42% |
| 9 | Mettler Toledo International | 23.53 Bn | 23.47 Bn | 555.82 Mn | -28.11% |
| 10 | Neogenomics | 1.48 Bn | 1.33 Bn | 80.86 Mn | 67.87% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 67.87% |
| Dec 31, 2025 | -86.30% |
| Sep 30, 2025 | -3.92% |
| Jun 30, 2025 | 46.34% |
| Mar 31, 2025 | 2.27% |
| Dec 31, 2024 | -44.89% |
| Sep 30, 2024 | 268.20% |
| Jun 30, 2024 | 997.42% |
| Mar 31, 2024 | -104.18% |
| Dec 31, 2023 | 582.61% |
| Sep 30, 2023 | 66.22% |
| Jun 30, 2023 | 90.89% |
| Mar 31, 2023 | 56.29% |
| Dec 31, 2022 | 81.37% |
| Sep 30, 2022 | -109.50% |
| Jun 30, 2022 | -1,122.73% |
| Mar 31, 2022 | -1,414.03% |
| Dec 31, 2021 | -430.43% |
| Sep 30, 2021 | -1,576.62% |
| Jun 30, 2021 | -173.86% |